UB Paderborn / Katalog / Suche / in CDI

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Journal of clinical oncology, 2014-08, Vol.32 (23), p.2423-2429

2014

Link zum Volltext

Verfügbarkeit prüfen

Sleep and take-over in automated driving

International Journal of Transportation Science and Technology, 2020-03, Vol.9 (1), p.42-51

2020

Link zum Volltext

Verfügbarkeit prüfen

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

Frontiers in oncology, 2021-07, Vol.11, p.670396-670396

2021

Link zum Volltext

Verfügbarkeit prüfen

Phasic left atrial strain to predict worsening of diastolic function: Results from the prospective Berlin Female Risk Evaluation follow-up trial

Frontiers in cardiovascular medicine, 2023-02, Vol.10, p.1070450-1070450

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of body mass index on worsening of diastolic function and impairment of left atrial strain in the general female urban population: a subanalysis of the Berlin female risk evaluation echocardiography follow-up study

Frontiers in cardiovascular medicine, 2023-09, Vol.10, p.1242805-1242805

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2028-2034

2015

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma

European journal of cancer (1990), 2017-09, Vol.83, p.290-301

2017

Link zum Volltext

Verfügbarkeit prüfen

TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial

Clinical cancer research, 2020-07, Vol.26 (14), p.3732-3739

2020

Link zum Volltext

Verfügbarkeit prüfen

Care: Praktiken und Politiken der Fürsorge: Ethnographische und geschlechtertheoretische Perspektiven

1, 2019

Link zum Volltext

Verfügbarkeit prüfen

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma

British journal of cancer, 2018-05, Vol.118 (11), p.1485-1491

2018

Link zum Volltext

Verfügbarkeit prüfen

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Blood, 2019-11, Vol.134 (Supplement_1), p.4969-4969

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma – A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials

European journal of cancer (1990), 2021-06, Vol.150, p.250-259

2021

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study

Oncology research and treatment, 2022-01, Vol.45 (4), p.178-185

2022

Link zum Volltext

Verfügbarkeit prüfen

Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group

Pancreas, 2016-04, Vol.45 (4), p.601-605

2016

Link zum Volltext

Verfügbarkeit prüfen

Influence of cytotoxic tumor-infiltrating T lymphocytes on outcome in resectable pancreatic cancer: Results from the CONKO 001 trial

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.281-281

2017

Link zum Volltext

Verfügbarkeit prüfen

Is gemcitabine (G) reuse possible in early recurrences after its adjuvant application in pancreatic adenocarcinoma (PA) treatment?

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15219-e15219

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of gemcitabine (Gem)-based palliative first-line therapy in the treatment of recurrent disease or of initially unresectable pancreatic cancer (PC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15218-e15218

2015

Link zum Volltext

Verfügbarkeit prüfen

Nabpaclitaxel plus gemcitabine in subjects with advanced pancreatic cancer who have cholestatic hyperbilirubenemia secondary to bile duct obstruction

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15717-e15717

2016

Link zum Volltext

Verfügbarkeit prüfen

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study

Journal of surgical oncology, 2013-11, Vol.108 (6), p.398-402

2013

Link zum Volltext

Verfügbarkeit prüfen

Adaptive transitions for automation in cars, trucks, buses and motorcycles

IET intelligent transport systems, 2020-08, Vol.14 (8), p.889-899

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of predictive factors for thromboembolic events in patients with advanced pancreatic cancer: Evaluation of the CONKO-004 (PROSPECT) study cohort

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4044-4044

2012

Link zum Volltext

Verfügbarkeit prüfen

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study: Long-Term Survival in Pancreatic Cancer

Journal of surgical oncology, 2013-11, Vol.108 (6), p.398-402

2013

Link zum Volltext

Verfügbarkeit prüfen

Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

Onkologie, 2012, Vol.35 (12), p.755-760

2012

Link zum Volltext

Verfügbarkeit prüfen

"Josef ist auf dem Weg"

Braunschweiger Beiträge für Theorie und Praxis von Ru und Ku, 2002 (4(102)), p.21-28

Bischoff, Sven

2002

Link zum Volltext

Verfügbarkeit prüfen

Semiconducting properties of polypyrrole films in aqueous solution

Journal of solid state electrochemistry, 1999-09, Vol.3 (7-8), p.406-411

1999

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Sleep and take-over in automated driving

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

Phasic left atrial strain to predict worsening of diastolic function: Results from the prospective Berlin Female Risk Evaluation follow-up trial

Impact of body mass index on worsening of diastolic function and impairment of left atrial strain in the general female urban population: a subanalysis of the Berlin female risk evaluation echocardiography follow-up study

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma

TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial

Care: Praktiken und Politiken der Fürsorge: Ethnographische und geschlechtertheoretische Perspektiven

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma – A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials

Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study

Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group

Influence of cytotoxic tumor-infiltrating T lymphocytes on outcome in resectable pancreatic cancer: Results from the CONKO 001 trial

Is gemcitabine (G) reuse possible in early recurrences after its adjuvant application in pancreatic adenocarcinoma (PA) treatment?

Outcomes of gemcitabine (Gem)-based palliative first-line therapy in the treatment of recurrent disease or of initially unresectable pancreatic cancer (PC)

Nabpaclitaxel plus gemcitabine in subjects with advanced pancreatic cancer who have cholestatic hyperbilirubenemia secondary to bile duct obstruction

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study

Adaptive transitions for automation in cars, trucks, buses and motorcycles

Evaluation of predictive factors for thromboembolic events in patients with advanced pancreatic cancer: Evaluation of the CONKO-004 (PROSPECT) study cohort

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study: Long-Term Survival in Pancreatic Cancer

Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

"Josef ist auf dem Weg"

Semiconducting properties of polypyrrole films in aqueous solution

Suchergebnisse filtern